Dr. Farbod Nicholas Rahaghi, MD, PhD

Dr. Rahaghi practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Rahaghi's NPI, 1720253156, was assigned on April 27, 2008. Dr. Rahaghi graduated from University of California, San Diego School of Medicine in 2008. Dr. Rahaghi holds Massachusetts license 246689.

Dr. Rahaghi's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Rahaghi's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Rahaghi to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rahaghi practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Rahaghi's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Rahaghi is licensed in Massachusetts.

CMS data shows 149 Medicare services from Dr. Rahaghi across 3 procedure codes in 2024, for 120 Medicare patients. Medicare paid $18,469 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 120 Medicare patients who saw Dr. Rahaghi in 2024. The largest group is 75 to 84, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 3.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rahaghi's median patient age at 63, with 56% women.

In 2024, Dr. Rahaghi wrote 92 Medicare Part D claims for 19 patients. 49% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $10,844 in total drug cost. In 2023, CMS named 60 claims across 3 drugs.

Dr. Rahaghi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rahaghi as offering telehealth.

Dmand AI links 58 papers to Dr. Rahaghi, published from 2014 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Tomography, X-Ray Computed, Pulmonary Artery and Pulmonary Disease, Chronic Obstructive. Dr. Rahaghi has published most often in Chest. Dr. Rahaghi's most frequent co-authors are George R. Washko, MD, Samuel Yoffe Ash, MD and Aaron B. Waxman, MD, PhD.

CMS Open Payments shows 77 general payments to Dr. Rahaghi from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $4,087.

Dr. Rahaghi graduated from University of California, San Diego School of Medicine in 2008.